In 2026, the battle against graft failure is being won through Bio-Active Surface Modifications, specifically Heparin-Bonded ePTFE. For years, the primary reason for graft replacement was thrombosis (clotting), but in 2026, advanced coatings are significantly reducing these events. These 2026 grafts, such as the latest iterations of the Gore PROPATEN, use surface-bound heparin to mimic the...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai
English
French
Spanish
Italiano
Romaian
Portuguese (Brazil)
china